|
IME Point of Sale Maintenance Window 71.02 KB |
|
2022/05/16 |
|
IME Point of Sale Maintenance Window 70.81 KB |
|
2022/05/16 |
|
PDL Changes Effective April 27, 2022 (Epogen) 46.94 KB |
|
2022/04/28 |
|
IME Point of Sale Maintenance Window 70.44 KB |
|
2022/03/02 |
|
IME Point of Sale Maintenance Window 70.43 KB |
|
2022/02/02 |
|
IME Point of Sale Maintenance Window 70.42 KB |
|
2022/01/10 |
|
IME Point of Sale Maintenance Window 69.08 KB |
|
2021/11/02 |
|
IME Point of Sale Maintenance Window 69.52 KB |
|
2021/10/08 |
|
PDL Changes Effective July 3, 2020 100.39 KB |
(methylphenidate er osmotic release tablet) |
2020/06/08 |
|
PDL Changes Effective April 12, 2019 42.66 KB |
(Octreotide) |
2019/03/28 |
|
PDL Changes Effective October 20, 2017 (levonorgestrel emergency contraception) 72.28 KB |
|
2017/10/16 |
|
IME Provider Portal Maintenance Window 106 KB |
|
2016/10/03 |
|
PDL Changes Effective May 31, 2013 (immediate release methylphenidate tablets) *Second Notice 11.46 KB |
|
2013/05/24 |